Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL2991328 | 0.97 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL20668551 | 0.85 | — | — | |
| SCHEMBL14127152 | 0.82 | — | — | |
| SCHEMBL5316 | 0.82 | — | — | |
| Ether SCHEMBL8961469 | 0.79 | ALDH1A1 (0.38) | ALDH1A1 | |
| Butane SCHEMBL2121237 | 0.79 | — | — | |
| Bromide SCHEMBL25315220 | 0.78 | — | — | |
| SCHEMBL15741725 | 0.78 | — | — | |
| Ether SCHEMBL703912 | 0.78 | ALDH1A1 (0.42) | ALDH1A1 | |
| Phosphine SCHEMBL4322491 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007140525-A1 | A METHOD OF TREATMENT AND PROPHYLAXIS OF EVENTS, CONDITIONS AND DISEASES OF THE SYSTEMIC VASCULATURE AN IMMUNE FUNCTION TO DECREASE CARDIOVASCULAR RISK AND PATHOGENIC INFECTION | HOENIG MICHEL (AU) | 2007-12-13 | — | — | WO | claimed |
| US-20230392039-A1 | COMPOUND, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING SURFACE TREATMENT AGENT | AGC Inc. (JP) | 2023-12-07 | — | — | US | disclosed |
| US-20230226807-A1 | Polymer Composites and Methods of Making the Same | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2023-07-20 | — | — | US | disclosed |
| WO-2023088965-A1 | METHOD FOR THE SYNTHESIS OF A METAL CATALYST SURROUNDED WITH A CARBON MATRIX | INSTITUT POLYTECHNIQUE DE GRENOBLE (FR) | 2023-05-25 | — | — | WO | disclosed |
| EP-4184620-A1 | METHOD FOR THE SYNTHESIS OF A METAL CATALYST SURROUNDED WITH A CARBON MATRIX | Institut Polytechnique de Grenoble (FR) | 2023-05-24 | — | — | EP | disclosed |
| US-20230023066-A1 | N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME CORP. (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2021226424-A1 | POLYMER COMPOSITES AND METHODS OF MAKING THE SAME | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-3436537-B1 | ANAEROBICALLY CURABLE (METH)ACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2021-09-29 | — | — | EP | disclosed |
| US-11111416-B2 | Anaerobically curable (meth)acrylate compositions | Henkel IP & Holding GmbH (DE) | 2021-09-07 | — | — | US | disclosed |
| US-11091504-B2 | Process for the preparation of tavaborole, its novel polymorphic forms and the polymorphs thereof | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2021-08-17 | — | — | US | disclosed |
| US-20150336862-A1 | CATALYTIC HYDROGENATION USING COMPLEXES OF BASE METALS WITH TRIDENTATE LIGANDS | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2015-11-26 | — | — | US | disclosed |
| US-20140303404-A1 | NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | EASTMAN CHEMICAL COMPANY (US) | 2014-10-09 | — | — | US | disclosed |
| US-8785697-B2 | Nickel modified catalyst for the production of hydroxy ether hydrocarbons by vapor phase hydrogenolysis of cyclic acetals and ketals | EASTMAN CHEMICAL COMPANY (US) | 2014-07-22 | — | — | US | disclosed |
| WO-2013041106-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS 11CO FOR CARBONYLATION REACTIONS IN THE PREPARATION OF RADIOPHARMACEUTICALS FOR PET IMAGING | AARHUS UNIVERSITET (DK) | 2013-03-28 | — | — | WO | disclosed |
| US-20120330068-A1 | NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | EASTMAN CHEMICAL COMPANY (US) | 2012-12-27 | — | — | US | disclosed |
| US-8293938-B2 | Alkylphosphonous acids, salts and esters, methods for the production thereof, and use of the same | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-10-23 | — | — | US | disclosed |
| US-8278243-B2 | Laser imaging | DATALASE LTD. (GB) | 2012-10-02 | — | — | US | disclosed |
| WO-2012079583-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS CO FOR CARBONYLATION REACTIONS | AARHUS UNIVERSITET (DK) | 2012-06-21 | — | — | WO | disclosed |
| US-20100075848-A1 | Laser Imaging | DATALASE LTD. (GB) | 2010-03-25 | — | — | US | disclosed |
| WO-2007140525-A1 | A METHOD OF TREATMENT AND PROPHYLAXIS OF EVENTS, CONDITIONS AND DISEASES OF THE SYSTEMIC VASCULATURE AN IMMUNE FUNCTION TO DECREASE CARDIOVASCULAR RISK AND PATHOGENIC INFECTION | HOENIG MICHEL (AU) | 2007-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120330068-A1 | NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | KAT5, HRH3, KAT8 | ALDH1A1 2375/4885 |
| US-20230392039-A1 | COMPOUND, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING SURFACE TREATMENT AGENT | SGMS2, SGMS1, BMP2 | ALDH1A1 2261/4885 |
| US-11091504-B2 | Process for the preparation of tavaborole, its novel polymorphic forms and the polymorphs thereof | HLA-B, VKORC1L1, VPS4B | ALDH1A1 1902/4885 |
| US-20230023066-A1 | N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | LRRK2, CLK2, PARK7 | ALDH1A1 4080/4885 |
| US-20140303404-A1 | NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS | KAT5, HRH3, KAT8 | ALDH1A1 2375/4885 |
| US-20150336862-A1 | CATALYTIC HYDROGENATION USING COMPLEXES OF BASE METALS WITH TRIDENTATE LIGANDS | HRH4, HRH3, CHD4 | ALDH1A1 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.